weight loss glp-1 Comparing Ozempic, Wegovy and Other Drugs Medically Supervised GLP-1 Weight Loss

Despite the benefits of weight reduction, there are many challenges in losing weight and maintaining long-term weight loss

This is the paradox at the heart of a new study

Get trusted legal help from Alexander Shunnarah Trial Attorneys

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications

Use just enough healthy fat for flavor, hormones, and ketone supportolive oil, avocado oil, butter in moderation

We published case reports and case series suggesting that these drugs may be beneficial for a large subset of patient population with #chronicillness.